Related Experiment Video

Updated: Jul 24, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

The role of angioplasty in acute myocardial infarction

G A Rose1, P T O'Gara

  • 1Cardiac Unit, Massachusetts General Hospital, Boston, USA.

Journal of Intensive Care Medicine
|June 7, 1995
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) is increasingly used for acute myocardial infarction (AMI) management. This review examines PTCA

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Management

Background:

  • The precise role of percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction (AMI) management remains under investigation.
  • Historically, PTCA has been utilized in AMI patients unsuitable for or unresponsive to thrombolytic therapy.
  • Current research explores direct PTCA as a primary reperfusion strategy for AMI.

Purpose of the Study:

  • To review the theoretical underpinnings of both thrombolytic therapy and PTCA in AMI.
  • To analyze the clinical evidence for PTCA across diverse AMI patient groups.
  • To provide guidance on the optimal application of both reperfusion strategies in AMI.

Main Methods:

  • Literature review of conceptual bases for thrombolytic therapy and PTCA in AMI.
  • Analysis of clinical experience with PTCA in various acute myocardial infarction patient populations.

Main Results:

  • PTCA is established for patients ineligible for or failed by thrombolysis.
  • Growing interest exists in using direct PTCA as the initial reperfusion method for AMI.
  • Clinical data guides the application of PTCA and thrombolysis in specific AMI scenarios.

Conclusions:

  • PTCA plays a defined role in specific acute myocardial infarction patient subsets.
  • Direct PTCA is emerging as a primary reperfusion strategy.
  • Evidence supports tailored use of PTCA and thrombolysis for optimal AMI outcomes.

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...